Taro`s Generic Oxiconazole Nitrate approved in US to treat skin infections
It's not just Valeant Pharmaceuticals ($VRX) that's raising prices on skin drugs. A new study shows that prices for 19 brand-name dermatology meds, including two from Valeant, have increased almost fivefold, on average, over the past 6 years.
Retail prices of 19 brand-name prescription drugs for dermatologic conditions ranging from acne to cancer increased fivefold on average between 2009 and 2015, according to a study that adds new fuel to the burgeoning debate over the cost of medicines.